Form D · Biotechnology
Exosome Diagnostics, Inc.
Waltham, MA · CIK 0001491340
Offering snapshot reported Jul 6, 2017 · SEC filing
- Reported sold
- $30.3M Offering amount: $30.3M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2017 | Initial | $30,290,634 | No comparison | 43 | SEC filing |
| Sep 15, 2015 | Initial | $15,530,538 | No comparison | 9 | SEC filing |
| Jul 6, 2015 | Initial | $1,483,973 | No comparison | 12 | SEC filing |
| Mar 13, 2014 | Initial | $27,092,442 | No comparison | 26 | SEC filing |
| Aug 15, 2013 | Amendment | $7,000,000 | $500,000vs Jun 11, 2013 | 2 | SEC filing |
| Jun 11, 2013 | Amendment | $6,500,000 | $1,500,000vs Feb 4, 2013 | 2 | SEC filing |
| Feb 4, 2013 | Amendment | $5,000,000 | $2,000,000vs Aug 23, 2012 | 2 | SEC filing |
| Aug 23, 2012 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| May 12, 2010 | Initial | $9,495,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290040
Source: Form D, filed Jul 6, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sara Barrington | Executive |
| John Boyce | Director, Executive |
| Joseph Boystak | Director |
| Wayne Comper | Executive |
| Kapil Dhingra | Director |
| Peter Johann | Director |
| Dhingra Kapil | Director |
| William Kelly | Executive |
| James Mc Cullough | Director, Executive |
| Thomas Mc Lain | Executive |
| Geert Jan Mulder | Director |
| Georg Nebgen | Director |
| David Okrongly | Executive |
| Joseph Slattery | Director |
| Steven Soignet | Director |
| Greg Zdechlik | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
266 2nd Avenue
Waltham, MA, 02451
Waltham, MA, 02451